| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
120,361 |
105,990 |
$7.47M |
| 0762 |
|
2,295 |
1,176 |
$1.91M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,064 |
4,921 |
$1.23M |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,044 |
4,918 |
$985K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,261 |
11,511 |
$864K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,701 |
12,741 |
$777K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,217 |
6,917 |
$634K |
| 0240U |
|
5,207 |
5,105 |
$594K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,170 |
17,579 |
$578K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,353 |
7,961 |
$549K |
| 80053 |
Comprehensive metabolic panel |
45,746 |
41,270 |
$472K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,000 |
7,758 |
$470K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,152 |
11,629 |
$399K |
| Z7502 |
|
10,979 |
10,685 |
$394K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
51,281 |
44,876 |
$338K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,873 |
1,838 |
$337K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,716 |
8,278 |
$309K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
11,013 |
10,717 |
$301K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,414 |
2,364 |
$290K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,457 |
2,911 |
$273K |
| 0361 |
|
1,474 |
1,057 |
$268K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,538 |
3,436 |
$266K |
| 71045 |
Radiologic examination, chest; single view |
17,307 |
16,309 |
$213K |
| J3490 |
Unclassified drugs |
70,223 |
34,937 |
$196K |
| 71046 |
Radiologic examination, chest; 2 views |
8,191 |
7,994 |
$193K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,690 |
2,618 |
$174K |
| 0710 |
|
5,749 |
5,034 |
$173K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,364 |
1,766 |
$166K |
| 84484 |
|
18,424 |
15,316 |
$153K |
| 0360 |
|
792 |
607 |
$149K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,805 |
1,665 |
$146K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,391 |
1,863 |
$139K |
| 83880 |
|
5,286 |
4,937 |
$136K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
744 |
739 |
$131K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,625 |
1,606 |
$129K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,747 |
3,645 |
$120K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,736 |
3,641 |
$120K |
| 0270 |
|
7,501 |
3,475 |
$116K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,620 |
1,595 |
$114K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
548 |
538 |
$111K |
| 83690 |
|
16,922 |
15,823 |
$110K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,567 |
3,278 |
$106K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,350 |
11,889 |
$104K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,312 |
1,654 |
$103K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,626 |
3,325 |
$98K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,598 |
1,529 |
$97K |
| 97750 |
|
1,522 |
931 |
$95K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,618 |
3,089 |
$95K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
366 |
362 |
$88K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,076 |
536 |
$86K |
| 81001 |
|
28,670 |
27,064 |
$85K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,231 |
5,989 |
$85K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
328 |
323 |
$83K |
| 87040 |
|
7,896 |
4,778 |
$79K |
| 76801 |
|
1,057 |
1,004 |
$76K |
| 87088 |
|
11,541 |
11,085 |
$74K |
| 90715 |
|
1,825 |
1,809 |
$73K |
| 73610 |
|
2,000 |
1,939 |
$63K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,329 |
1,272 |
$61K |
| 81025 |
|
15,084 |
14,325 |
$60K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,362 |
4,246 |
$58K |
| 73630 |
|
2,053 |
1,975 |
$56K |
| 93971 |
|
471 |
462 |
$56K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,557 |
10,071 |
$56K |
| 84702 |
|
3,494 |
3,260 |
$52K |
| 94644 |
|
2,012 |
1,843 |
$49K |
| 73030 |
|
1,396 |
1,341 |
$49K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
689 |
677 |
$48K |
| 73130 |
|
1,643 |
1,586 |
$47K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,775 |
8,936 |
$46K |
| 73562 |
|
1,749 |
1,629 |
$46K |
| 96367 |
|
942 |
923 |
$45K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,459 |
5,070 |
$44K |
| 82077 |
|
1,736 |
1,628 |
$43K |
| 83605 |
|
4,455 |
3,911 |
$41K |
| 93970 |
|
240 |
239 |
$41K |
| 82805 |
|
1,737 |
1,638 |
$39K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
305 |
301 |
$38K |
| 99199 |
Unlisted special service, procedure or report |
652 |
524 |
$38K |
| 87077 |
|
4,867 |
4,636 |
$38K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,681 |
2,575 |
$37K |
| 87186 |
|
3,938 |
3,705 |
$36K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,535 |
4,675 |
$35K |
| J2785 |
Injection, regadenoson, 0.1 mg |
250 |
246 |
$34K |
| 86141 |
|
3,133 |
3,063 |
$34K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
123 |
120 |
$33K |
| 97010 |
|
1,785 |
641 |
$29K |
| 73110 |
|
998 |
964 |
$29K |
| 83735 |
|
4,712 |
3,654 |
$29K |
| 85730 |
|
5,647 |
5,381 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,094 |
3,624 |
$28K |
| 70486 |
|
124 |
122 |
$26K |
| 80179 |
|
945 |
896 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
644 |
638 |
$25K |
| 85610 |
|
7,365 |
6,923 |
$25K |
| 82550 |
|
4,092 |
3,878 |
$24K |
| J1815 |
Injection, insulin, per 5 units |
1,085 |
619 |
$24K |
| 80143 |
|
896 |
844 |
$24K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
108 |
108 |
$23K |
| 87070 |
|
2,815 |
2,770 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,825 |
2,787 |
$22K |
| 96368 |
|
872 |
864 |
$22K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
795 |
794 |
$22K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
672 |
542 |
$21K |
| 74150 |
|
106 |
103 |
$20K |
| 82947 |
|
5,229 |
3,450 |
$20K |
| 93017 |
|
347 |
341 |
$19K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,101 |
1,558 |
$19K |
| 85379 |
|
2,073 |
2,030 |
$19K |
| 62321 |
|
76 |
66 |
$19K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,908 |
1,566 |
$16K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
403 |
365 |
$16K |
| 72110 |
|
304 |
303 |
$15K |
| 82553 |
|
1,480 |
1,444 |
$15K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
106 |
104 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,312 |
2,232 |
$13K |
| 84100 |
|
2,860 |
2,229 |
$13K |
| 0160 |
|
175 |
110 |
$12K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,727 |
1,663 |
$12K |
| 84703 |
|
1,846 |
1,804 |
$12K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,566 |
2,370 |
$12K |
| 86850 |
|
2,951 |
2,828 |
$12K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,408 |
2,213 |
$11K |
| 0250 |
|
3,696 |
1,810 |
$11K |
| 29125 |
|
217 |
210 |
$10K |
| 76830 |
Ultrasound, transvaginal |
143 |
139 |
$10K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
368 |
368 |
$10K |
| 73080 |
|
337 |
331 |
$9K |
| 0761 |
|
212 |
101 |
$9K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
131 |
126 |
$8K |
| 86900 |
|
2,964 |
2,828 |
$8K |
| 86901 |
|
2,960 |
2,827 |
$8K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,019 |
1,563 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
411 |
405 |
$8K |
| 93880 |
|
67 |
65 |
$7K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
9,776 |
4,740 |
$7K |
| 83021 |
|
520 |
500 |
$7K |
| 99292 |
|
28 |
28 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
1,255 |
1,091 |
$7K |
| Z7610 |
|
3,217 |
1,829 |
$7K |
| 81002 |
|
3,001 |
2,924 |
$7K |
| 64484 |
|
664 |
553 |
$6K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,713 |
1,306 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,245 |
1,198 |
$6K |
| 74019 |
|
217 |
215 |
$6K |
| 73590 |
|
247 |
231 |
$5K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
643 |
575 |
$5K |
| J1644 |
Injection, heparin sodium, per 1000 units |
738 |
410 |
$5K |
| 64483 |
|
634 |
543 |
$5K |
| 87210 |
|
1,206 |
1,181 |
$5K |
| 74018 |
|
241 |
235 |
$5K |
| 81015 |
|
2,050 |
1,990 |
$5K |
| 73140 |
|
275 |
267 |
$5K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
471 |
365 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,053 |
5,295 |
$4K |
| 86592 |
|
968 |
833 |
$4K |
| 12001 |
|
225 |
225 |
$4K |
| 71020 |
|
137 |
64 |
$4K |
| J1940 |
Injection, furosemide, up to 20 mg |
420 |
286 |
$3K |
| 82150 |
|
589 |
580 |
$3K |
| 87420 |
|
828 |
801 |
$3K |
| 10060 |
|
150 |
147 |
$3K |
| 73090 |
|
123 |
115 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
530 |
423 |
$3K |
| 85652 |
|
913 |
889 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
116 |
112 |
$3K |
| 0370 |
|
48 |
41 |
$3K |
| G0378 |
Hospital observation service, per hour |
29 |
28 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,734 |
5,015 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
231 |
215 |
$2K |
| 82330 |
|
178 |
172 |
$2K |
| 29515 |
|
15 |
13 |
$2K |
| 27096 |
|
36 |
36 |
$2K |
| 73502 |
|
66 |
63 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
139 |
113 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
166 |
166 |
$2K |
| 80061 |
Lipid panel |
154 |
146 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
149 |
125 |
$1K |
| 84145 |
|
77 |
76 |
$1K |
| 86703 |
|
116 |
115 |
$1K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
97 |
96 |
$990.68 |
| 93226 |
|
12 |
12 |
$872.64 |
| 71100 |
|
26 |
25 |
$811.68 |
| 94760 |
|
85 |
70 |
$808.68 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$655.41 |
| 86803 |
|
52 |
51 |
$651.45 |
| 99406 |
|
57 |
54 |
$647.77 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
256 |
232 |
$641.99 |
| 84439 |
|
83 |
79 |
$576.71 |
| 71010 |
|
32 |
14 |
$536.51 |
| 72050 |
|
12 |
12 |
$517.35 |
| 82009 |
|
136 |
131 |
$501.07 |
| 72100 |
|
14 |
14 |
$468.68 |
| 93225 |
|
12 |
12 |
$465.24 |
| 97116 |
|
29 |
15 |
$463.14 |
| 12002 |
|
24 |
24 |
$391.13 |
| 29540 |
|
42 |
42 |
$342.03 |
| J0456 |
Injection, azithromycin, 500 mg |
46 |
39 |
$334.83 |
| 82140 |
|
26 |
24 |
$272.17 |
| 87205 |
|
71 |
68 |
$235.66 |
| 80076 |
|
40 |
39 |
$219.38 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
26 |
24 |
$212.25 |
| 82728 |
|
14 |
14 |
$172.36 |
| 0324 |
|
12 |
12 |
$167.74 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
25 |
24 |
$147.37 |
| 36600 |
|
45 |
41 |
$139.65 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
14 |
12 |
$127.55 |
| A4615 |
Cannula, nasal |
92 |
81 |
$91.04 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
20 |
15 |
$90.82 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
25 |
25 |
$58.35 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
54 |
27 |
$39.98 |
| 0272 |
|
633 |
520 |
$22.92 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
56 |
55 |
$7.60 |
| 36415 |
Collection of venous blood by venipuncture |
324 |
319 |
$0.00 |
| A9270 |
Non-covered item or service |
113 |
75 |
$0.00 |
| 0271 |
|
12 |
12 |
$0.00 |